SHANGHAI PHARM. H YC1

SHANGHAI PHARM. H YC1

Share · CNE1000012B3 · A1JAWQ (XHKG)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SHANGHAI PHARM. H YC1
No Price
29.04.2026 05:27
Current Prices from SHANGHAI PHARM. H YC1
ExchangeTickerCurrencyLast TradePriceDaily Change
XDQU: Quotrix
Quotrix
SPHRSHB3.DUSD
EUR
29.04.2026 05:27
1,27 EUR
0,00 EUR
XDUS: Düsseldorf
Düsseldorf
SPHRSHB3.DUSB
EUR
28.04.2026 14:00
1,16 EUR
-0,11 EUR
-8,66 %
OTC: UTC
UTC
SHPMF
USD
23.04.2026 13:30
1,46 USD
-
Invested Funds

The following funds have invested in SHANGHAI PHARM. H YC1:

Fund
iShares MSCI EM SRI UCITS ETF USD (Acc)
Vol. in million
2.615,69
Percentage (%)
0,10 %
Fund
iShares MSCI EM SRI UCITS ETF USD (Dist)
Vol. in million
231,21
Percentage (%)
0,10 %
Fund
iShares MSCI EM ESG Enhanced UCITS ETF USD (Acc)
Vol. in million
683,60
Percentage (%)
0,06 %
Fund
iShares MSCI EM ESG Enhanced UCITS ETF USD (Dist)
Vol. in million
162,33
Percentage (%)
0,06 %
Fund
iShares MSCI AC Far East ex-Japan UCITS ETF USD (Acc)
Vol. in million
5,21
Percentage (%)
0,02 %
Company Profile for SHANGHAI PHARM. H YC1 Share
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

Company Data

Name SHANGHAI PHARM. H YC1
Company Shanghai Pharmaceuticals Holding Co., Ltd
Website https://www.sphchina.com
Primary Exchange XHKG HKEX
WKN A1JAWQ
ISIN CNE1000012B3
Asset Class Share
Sector Healthcare
Industry Medical - Distribution
CEO Qiuhua Yang
Market Capitalization 8 Mrd.
Country China
Currency EUR
Employees 49,4 T
Address Shanghai Pharmaceutical Building, 200020 Shanghai
IPO Date 2013-01-22
Dividends from 'SHANGHAI PHARM. H YC1'
Ex-Date Dividend per Share
29.12.2025 0,02 USD
17.07.2025 0,32 HKD
16.07.2025 0,04 USD
19.09.2024 0,09 HKD
17.09.2024 0,01 USD
19.07.2024 0,44 HKD
18.07.2024 0,06 USD
18.07.2023 0,09 USD
20.07.2022 0,49 HKD
16.07.2021 0,58 HKD

Ticker Symbols

Name Symbol
Over The Counter SHPMF
Düsseldorf SPHRSHB3.DUSB
Frankfurt S1R.F
Quotrix SPHRSHB3.DUSD
More Shares
Investors who hold SHANGHAI PHARM. H YC1 also have the following shares in their portfolio:
NORDLB IS.S.1541
NORDLB IS.S.1541 Bond
UniCredit Bank GmbH OPEN END ZT(06/unlim.) S&P200
UniCredit Bank GmbH OPEN END ZT(06/unlim.) S&P200 Bond